<DOC>
	<DOCNO>NCT02546843</DOCNO>
	<brief_summary>This randomize study prospectively evaluate experience administration cisatracurium rocuronium antagonize sugammadex evaluate effect various depth neuromuscular blockage provide optimal surgical condition laparoscopy low-pressure capnoperitoneum .</brief_summary>
	<brief_title>Depth Neuromuscular Blockade Perioperative Conditions Laparoscopic Surgery Pediatric Population</brief_title>
	<detailed_description>This randomize study prospectively evaluate experience administration cisatracurium rocuronium antagonize sugammadex evaluate effect various depth neuromuscular blockage provide optimal surgical condition laparoscopy low-pressure capnoperitoneum . After meet inclusion criterion patient randomize - - use opaque envelope , randomization group A B operate theatre , study blind patient ( his/her legal guardian ) surgeon . Group A - muscle relaxation use rocuronium follow sugammadex reversal ( dose accord TOF - ( train-of-four ) 2-4mg/kg ) , depth muscle relaxation TOF 0 PTC ( post-tetanic count ) 0-1 Group B - muscle relaxation use cisatracurium follow decurarization ( neostigmine 0.03 mg/kg atropine 0.02 mg/kg ) Anesthesia management : - intravenous cannulation , preoxygenation , sufentanil 0.2 μg/kg intravenously , propofol 2.0mg/kg Group A - rocuronium 0.6 mg/kg ( 1 mg/kg case rapid sequence induction ) , Group B - cisatracurium 0.15mg/kg - orotracheal intubation , combine anesthesia use sevoflurane - MAC ( minimal alveolar concentration ) 1.0 respect age patient - ventilation : PCV ( pressure-controlled ventilation ) , PEEP ( positive end-expiratory pressure ) +5 cm H2O ( aqua ) , normocapnia , FiO2 ( fraction inspire oxygen ) 1.0 intubation , afterwards 0.4 + AIR - nasogastric tube placement Management neuromuscular blockade : Group A - maintain deep muscular blockage - accord TOF 0 , PTC 0-1 , boluses rocuronium 0.3 mg/kg allow Group B - maintain muscular relaxation TOF 1 , boluses cisatracurium 0.03 mg/kg allow Laparoscopy - capnoperitoneum pressure - 10 mmHg reduction 8 mmHg possible During surgery surgical condition score use Surgical score system : ( 1-2 surgeon involve ) : 1 . Optimal condition : wide laparoscopic field , movement contraction 2 . Good condition : wide laparoscopic field singular movement muscle contraction 3 . Acceptable condition : wide laparoscopic field muscle contraction and/or movement occur regularly . Additional neuromuscular block agent require . 4 . Poor condition : grade 3 addition , hazard tissue damage . 5 . Extremely poor condition : surgeon work weak muscle relaxation , patient coughing . Additional neuromuscular blocking agent essential . Recovery anesthesia : - extubation - TOF 0.9 - use sugammadex Group A ( 2-4 mg/kg accord depth muscle relaxation ) decurarization Group B ( atropine 0.02 mg/kg neostigmine 0.03mg/kg ) - standard 2-hour monitoring recovery room ( heart rate , blood pressure , SpO2 ( oxygen saturation pulse oximetry ) , level consciousness , PONV ) , patient observe intensive care unit least 24 hour Statistical analysis : ( provide IBA MUNI - Institute biostatistic analysis Masaryk University Brno , Czech Republic ) - demographic parameter - age , gender , type duration surgery - induction general anesthesia - time intubation ( recognition capnogram curve ) - ventilation - change inspiratory pressure capnoperitoneum , increase EtCO2 ( end-tidal CO2 ) - capnoperitoneal pressure - surgical scoring system</detailed_description>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>pediatric patient age 2 17 year ( + 364 day ) eligible laparoscopy ( diagnostic laparoscopy , appendectomy , cholecystectomy , nephrectomy , splenectomy , tumor biopsy , varicocele correction , testicular retention ) fast least 6 hour ASA ( American Society Anesthesiology score ) score 1 2 sign inform consent legal guardian patient disagreement patient his/her legal guardian serious comorbidities renal hepatic disorder ASA score ≥ 3</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>rocuronium</keyword>
	<keyword>sugammadex</keyword>
	<keyword>pediatric anesthesia</keyword>
	<keyword>cisatracurium</keyword>
	<keyword>surgical condition</keyword>
</DOC>